Established in 1992, this manufacturer employs approximately 892 individuals and specializes in pharmaceutical finished dosage forms, active pharmaceutical ingredients (APIs), and drug intermediates. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple countries, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for metered dose inhalers, dry powder inhalers, nebulization solutions, and tablets, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in over 25 countries worldwide. With a focus on innovation, the manufacturer is a CTD dossier owner and manufacturer, dedicated to developing high-quality pharmaceutical solutions.

Established in 2020, this manufacturer employs approximately 677 individuals and specializes in providing comprehensive pharmaceutical manufacturing services, including product development, analytical and regulatory services, as well as clinical and commercial manufacturing and packaging for various dosage forms. As a CTD dossier owner and manufacturer, it holds GMP certifications from international regulatory authorities, ensuring compliance with stringent quality standards. The manufacturer operates advanced production lines adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in over 20 countries worldwide.